SCHEMBL20072477

SCHEMBL20072477

COSc1ccc(C(C)C)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.40
SMN1; SMN2 Q16637 3/20 0.39
ALDH1A1 P00352 3/20 0.39
IDO1 P14902 2/20 0.39
TYR P14679 2/20 0.38
BCL2 P10415 1/20 0.36
MCL1 Q07820 1/20 0.36
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
HPGD P15428 1/20 0.35
RAB9A P51151 1/20 0.35
DDB1 Q16531 1/20 0.35
CRBN Q96SW2 1/20 0.35
GAA P10253 2/20 0.34
ALOX12 P18054 1/20 0.34
HIF1A Q16665 1/20 0.34
NFKB1 P19838 1/20 0.34
LMNA P02545 3/20 0.34
ALOX5 P09917 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4547844 0.82 IDO1 (0.36) HTTSMN1; SMN2ALDH1A1IDO1TYR
SCHEMBL23894557 0.77 LMNA (0.40) HTTSMN1; SMN2ALDH1A1IDO1TYR
SCHEMBL13542565 0.76 IDO1 (0.35) HTTSMN1; SMN2ALDH1A1IDO1TYR
SCHEMBL20072439 0.74 HDAC4 (0.46) HTTSMN1; SMN2ALDH1A1TYRL3MBTL1
SCHEMBL2279013 0.74 MCL1 (0.53) HTTALDH1A1IDO1TYRBCL2
SCHEMBL944020 0.74 TYR (0.44) HTTSMN1; SMN2ALDH1A1IDO1TYR
SCHEMBL30950300 0.73 TSHR (0.46) SMN1; SMN2ALDH1A1HIF1ANFKB1LMNA
SCHEMBL104124 0.72 TYR (0.58) HTTALDH1A1IDO1TYRHPGD
SCHEMBL10012057 0.72 HTT (0.44) HTTSMN1; SMN2ALDH1A1IDO1TYR
SCHEMBL4556108 0.72 SLC6A4 (0.52) HTTALDH1A1TYRALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11225469-B2 Inhibitors of phosphoglycerate dehydrogenase (PHGDH) and uses thereof WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH (US) 2022-01-18 US disclosed
US-20180105508-A1 INHIBITORS OF PHOSPHOGLYCERATE DEHYDROGENASE (PHGDH) AND USES THEREOF WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH (US) 2018-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11225469-B2 Inhibitors of phosphoglycerate dehydrogenase (PHGDH) and uses thereof PHGDH, PGD, PGK1 HTT 3947/4885SMN1; SMN2 4644/4885ALDH1A1 819/4885
US-20180105508-A1 INHIBITORS OF PHOSPHOGLYCERATE DEHYDROGENASE (PHGDH) AND USES THEREOF PHGDH, PGD, PGK1 HTT 4018/4885SMN1; SMN2 4643/4885ALDH1A1 778/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.